|
|
|
| 현재위치 : 홈 > 도서목록 > 전체도서목록 > 통계 |
| Integrated Cardiac Safety: Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance |
|
|
|
| 지은이 |
: Turner |
| 발행일 |
: 2009 년 |
| ISBN |
: 9780470229644 |
| 정행가 |
: 44,000 원 |
| 페이지 |
: 470 페이지 |
| 판행수 |
: 1판 |
| 출판사 |
: Wiley |
|
|
|
|
| 저자 및 역자 소개 |
|
|
|
|
| 차례 |
PartA I: INTRODUCTION
1. The Importance of Cardiac Safety Assessments
2. The Biological Basis of Adverse Drug Reactions
PartA II: CARDIAC FUNCTION AND PATHOLOGY
3. Cardiac Structure and Function
4. Cardiac Pathophysiology and Disease
SECTION III: DRUG DISCOVERY AND NONCLINICAL DEVELOPMENT
5. Drug Discovery and Drug Design
6. Nonclinical Development
SECTION IV: PREAPPROVAL CLINICAL DEVELOPMENT
7. The Thorough QT/QTc Trial
8. General Safety Assessments
SECTION V: POSTMARKETING ASSESSMENT METHODOLOGIES
9. Therapeutic Use Trials and Meta-analyses
10. Assessment Methodologies in Nonexperimental Postmarketing Surveillance
11. Postmarketing Proarrythmic Cardiac Safety Assessments
12. Generalized Cardiac Safety
SECTION VI: BEHAVIORAL DRUG SAFETY
13. Medication Errors, Adherence, and Concordance
SECTION VII: INTEGRATIVE DISCUSSION
14. Future Directions in Drug Safety
|
|
Zumdahl,줌달,맥머리
확대보기
